• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖相关性肾小球病:体重指数与蛋白尿。

Obesity-related glomerulopathy: body mass index and proteinuria.

机构信息

Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.

出版信息

Clin J Am Soc Nephrol. 2010 Aug;5(8):1401-9. doi: 10.2215/CJN.01370210. Epub 2010 May 24.

DOI:10.2215/CJN.01370210
PMID:20498244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2924407/
Abstract

BACKGROUND AND OBJECTIVES

Obesity-related glomerulopathy (ORG) is an increasing cause of end-stage renal disease, but evidence concerning the effects of treatments is rather limited. This study was aimed at exploring the renoprotective effects of weight loss on patients with ORG.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 63 patients with renal biopsy-proven ORG had food and exercise intervention in the physician-supervised weight loss program and were divided into three groups on the basis of the percentage of weight change from baseline to follow-up: significant weight loss (>3% reduction in body mass index [BMI]), stable weight, or significant weight gain (>3% increase). Metabolic parameters and renal lesions were evaluated regularly for 2 years.

RESULTS

After 6 months, 27 patients lost weight by 8.29 +/- 4.00%, with a mean decrease in proteinuria of 35.3%, whereas 24 months later, 27 patients achieved a 9.20 +/- 3.78% reduction in BMI and a 51.33% reduction in urine protein secretion. The levels of serum triglyceride, serum uric acid, and BP were also decreased. Contrarily, in patients with increased BMI, urine protein was increased by 28.78%. Correlation analysis showed proteinuria was associated with BMI, serum triglyceride, and uric acid, and multivariate regression analysis indicated the changes in BMI were the only predictor of proteinuria (P < 0.01).

CONCLUSIONS

Weight loss intervention benefited remission of proteinuria in patients with ORG, whose function could not be replaced by conventional pharmacotherapy.

摘要

背景与目的

肥胖相关性肾小球病(ORG)是导致终末期肾病的一个日益增多的原因,但关于治疗效果的证据相当有限。本研究旨在探讨减肥对 ORG 患者的肾脏保护作用。

设计、设置、参与者和测量:共有 63 例经肾活检证实的 ORG 患者在医生监督下的减肥计划中接受饮食和运动干预,并根据体重从基线到随访的变化百分比分为三组:体重显著减轻(体重指数[BMI]降低>3%)、体重稳定或体重显著增加(BMI 增加>3%)。定期评估代谢参数和肾脏病变 2 年。

结果

6 个月后,27 例患者体重减轻 8.29±4.00%,蛋白尿平均减少 35.3%,24 个月后,27 例患者 BMI 降低 9.20±3.78%,尿蛋白分泌减少 51.33%。血清甘油三酯、尿酸和血压水平也降低。相反,在 BMI 增加的患者中,尿蛋白增加了 28.78%。相关分析显示蛋白尿与 BMI、血清甘油三酯和尿酸有关,多元回归分析表明 BMI 的变化是蛋白尿的唯一预测因素(P<0.01)。

结论

体重减轻干预有益于 ORG 患者蛋白尿的缓解,其功能不能被传统的药物治疗所替代。

相似文献

1
Obesity-related glomerulopathy: body mass index and proteinuria.肥胖相关性肾小球病:体重指数与蛋白尿。
Clin J Am Soc Nephrol. 2010 Aug;5(8):1401-9. doi: 10.2215/CJN.01370210. Epub 2010 May 24.
2
Obesity-related glomerulopathy: an emerging epidemic.肥胖相关肾小球病:一种新出现的流行病。
Kidney Int. 2001 Apr;59(4):1498-509. doi: 10.1046/j.1523-1755.2001.0590041498.x.
3
Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies.体重减轻对超重慢性蛋白尿性肾病患者的有益影响。
Am J Kidney Dis. 2003 Feb;41(2):319-27. doi: 10.1053/ajkd.2003.50039.
4
Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study.肥胖型糖尿病合并慢性肾脏病患者的有氧运动:一项随机对照的初步研究。
Cardiovasc Diabetol. 2009 Dec 9;8:62. doi: 10.1186/1475-2840-8-62.
5
Weight loss and proteinuria.体重减轻和蛋白尿。
Contrib Nephrol. 2006;151:221-229. doi: 10.1159/000095332.
6
Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.肥胖相关性肾小球病:发病机制、病理、临床特征及治疗。
Front Med. 2017 Sep;11(3):340-348. doi: 10.1007/s11684-017-0570-3. Epub 2017 Aug 8.
7
Obesity-related glomerulopathy in China: a case series of 90 patients.中国的肥胖相关性肾小球病:90例患者的病例系列
Am J Kidney Dis. 2008 Jul;52(1):58-65. doi: 10.1053/j.ajkd.2008.02.303. Epub 2008 Apr 18.
8
Effects of body-weight loss and captopril treatment on proteinuria associated with obesity.体重减轻和卡托普利治疗对肥胖相关蛋白尿的影响。
Nephron. 1995;70(1):35-41. doi: 10.1159/000188541.
9
Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.肥胖慢性肾脏病患者应用奥利司他、营养教育、饮食和运动减肥的非随机试验:2 年随访结果。
Am J Kidney Dis. 2010 Jan;55(1):69-76. doi: 10.1053/j.ajkd.2009.09.011. Epub 2009 Nov 17.
10
Clinical features and long-term renal outcomes of Japanese patients with obesity-related glomerulopathy.肥胖相关性肾小球病日本患者的临床特征和长期肾脏预后。
Clin Exp Nephrol. 2013 Jun;17(3):379-85. doi: 10.1007/s10157-012-0719-y. Epub 2012 Nov 8.

引用本文的文献

1
Obesity-related glomerulopathy: How it happens and future perspectives.肥胖相关性肾小球病:发病机制及未来展望
Diabet Med. 2025 Jun;42(6):e70042. doi: 10.1111/dme.70042. Epub 2025 Apr 14.
2
Obesity-Related Chronic Kidney Disease: From Diagnosis to Treatment.肥胖相关慢性肾脏病:从诊断到治疗
Diagnostics (Basel). 2025 Jan 14;15(2):169. doi: 10.3390/diagnostics15020169.
3
Kidney consequences of obesity.肥胖对肾脏的影响
Pediatr Nephrol. 2025 Jun;40(6):1879-1893. doi: 10.1007/s00467-024-06623-y. Epub 2024 Dec 16.
4
New Perspectives on Obesity-Associated Nephropathy from Pathophysiology to Therapeutics: Revealing the Promise of GLP-1 RA Therapy.从病理生理学到治疗学:肥胖相关性肾病的新视角——揭示 GLP-1RA 治疗的前景。
Drug Des Devel Ther. 2024 Sep 23;18:4257-4272. doi: 10.2147/DDDT.S476815. eCollection 2024.
5
IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis.国际小儿肾脏病协会(IPNA)关于IgA肾病和IgA血管炎肾炎患儿诊断与管理的临床实践建议。
Pediatr Nephrol. 2025 Feb;40(2):533-569. doi: 10.1007/s00467-024-06502-6. Epub 2024 Sep 27.
6
A Random Forest Algorithm for Assessing Risk Factors Associated With Chronic Kidney Disease: Observational Study.一种用于评估慢性肾脏病相关危险因素的随机森林算法:观察性研究。
Asian Pac Isl Nurs J. 2024 Jun 3;8:e48378. doi: 10.2196/48378.
7
The New Challenge of Obesity - Obesity-Associated Nephropathy.肥胖的新挑战——肥胖相关性肾病
Diabetes Metab Syndr Obes. 2024 May 6;17:1957-1971. doi: 10.2147/DMSO.S433649. eCollection 2024.
8
Body mass index modifies the effect of urinary protein-to-creatinine ratio on chronic kidney disease progression.体重指数会改变尿蛋白/肌酐比值对慢性肾脏病进展的影响。
Int Urol Nephrol. 2024 Jul;56(7):2371-2378. doi: 10.1007/s11255-024-03984-z. Epub 2024 Feb 26.
9
Childhood Obesity: Insight into Kidney Involvement.儿童肥胖症:对肾脏受累的深入了解。
Int J Mol Sci. 2023 Dec 12;24(24):17400. doi: 10.3390/ijms242417400.
10
Understanding and Treatment Strategies of Hypertension and Hyperkalemia in Chronic Kidney Disease.慢性肾脏病中高血压与高钾血症的认识及治疗策略
Electrolyte Blood Press. 2023 Jun;21(1):24-33. doi: 10.5049/EBP.2023.21.1.24. Epub 2023 Jun 27.

本文引用的文献

1
Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007.1991 年至 2007 年中国农村地区高血压前期和高血压的流行情况。
Hypertens Res. 2010 Apr;33(4):331-7. doi: 10.1038/hr.2009.235. Epub 2010 Jan 22.
2
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis.慢性肾脏病患者的减肥干预措施:系统评价和荟萃分析。
Clin J Am Soc Nephrol. 2009 Oct;4(10):1565-74. doi: 10.2215/CJN.02250409. Epub 2009 Sep 17.
3
Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results.腹腔镜袖状胃切除术:1 年和 2 年结果的回顾性研究。
Surg Endosc. 2010 Apr;24(4):781-5. doi: 10.1007/s00464-009-0619-8. Epub 2009 Aug 19.
4
Effects of weight loss induced by bariatric surgery on the prevalence of metabolic syndrome.减重手术引起的体重减轻对代谢综合征患病率的影响。
Arq Bras Cardiol. 2009 Jun;92(6):418-22, 435-9, 452-6. doi: 10.1590/s0066-782x2009000600007.
5
Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.肥胖对非糖尿病慢性肾脏病进展的影响:一项回顾性队列研究。
Nephron Clin Pract. 2009;113(1):c16-23. doi: 10.1159/000228071. Epub 2009 Jul 10.
6
A review and meta-analysis of the effect of weight loss on all-cause mortality risk.体重减轻对全因死亡风险影响的综述与荟萃分析。
Nutr Res Rev. 2009 Jun;22(1):93-108. doi: 10.1017/S0954422409990035.
7
Association between changes in obesity parameters and incidence of chronic kidney disease in Japanese individuals.日本人群中肥胖参数变化与慢性肾脏病发病的相关性。
Kidney Blood Press Res. 2009;32(2):141-9. doi: 10.1159/000215739. Epub 2009 Apr 30.
8
Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein.减肥手术后体重减轻程度与蛋白尿及C反应蛋白降低之间的关系。
Surg Obes Relat Dis. 2009 Jan-Feb;5(1):20-6. doi: 10.1016/j.soard.2008.07.011. Epub 2008 Aug 5.
9
Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery.肥胖相关的局灶节段性肾小球硬化:一名青少年在减重手术后蛋白尿恢复正常
Pediatr Nephrol. 2009 Apr;24(4):851-5. doi: 10.1007/s00467-008-1024-6. Epub 2008 Oct 22.
10
Decreased body mass index as an independent risk factor for developing chronic kidney disease.体重指数降低作为慢性肾脏病发生的独立危险因素。
Clin Exp Nephrol. 2009 Feb;13(1):55-60. doi: 10.1007/s10157-008-0085-y. Epub 2008 Oct 7.